logo
Home Publications About the Authors
About the Authors
Deutsch Englisch
Contact Impressum Data Protection Login
logo
Home Publications About the Authors
About the Authors
Deutsch Englisch
Contact Impressum Data Protection Login

KONTAKTINFORMATIONEN

 

Deutsches Arzneiprüfungsinstitut e. V. (DAPI)
Heidestraße 7
10557 Berlin
Tel. +49 30 / 40004-572
Fax +49 30 / 40004-573
Internet: www.dapi.de
E-Mail: info(at)dapi.de

Prof. Dr. med. Mahfoud, Felix
Klinik für Innere Medizin III, Universitätsklinikum des Saarlandes
Publications:
Changes in utilization of antihypertensive drugs following angiotensin receptor blocker product recalls in Germany
Impact On Antihypertensive Prescribing After The Dear Healthcare Professional Letter On Increased Risk Of Skin Cancer Related To Hydrochlorothiazide
Use of fixed‑dose combination antihypertensives in Germany between 2016 and 2020: an example of guideline inertia
Trends in Ezetimibe Prescriptions as Monotherapy or Fixed-Dose Combination in Germany 2012–2021
“Dear Doctor” Warning Letter (Rote-Hand-Brief) on Hydrochlorothiazide and Its Impact on Antihypertensive Prescription
Impact of angiotensin receptor blocker product recalls on antihypertensive prescribing in Germany
DAPI
News
Publications
Members